X

Camson Bio Technologies Ltd. Stock Analysis

Small Cap
Evaluated by 441 users | BSE: 538858 | NSE: |
Agriculture
Camson, incorporated in 1993 is India's first wholly integrated Agriculture Biotechnology, is based at Bangalore, garden city of India. It became a Public Company in 1995. Camson has been promoted by technocrats with vast relevant experience. Its Vision is to create a healthy and disease free...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 23.46%23.96%17.05%14.35%7.88%2.09%-15.19%-13.59%-6.27%-20.09%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 8098.711212014616925.410.419.35
Y-o-Y Gr. Rt.-23.5%13.7%6.6%21.8%16.3%-85%-59.3%86.6%-74.2%
Adjusted EPS (Rs.) 8.5112.1411.4312.696.251.02-12.61-7.73-3.74-7.3
Y-o-Y Gr. Rt.-42.7%-5.9%11%-50.8%-83.7%-1336.3%NANANA
Book Value per Share (Rs.) 43.2257.8569.2780.880.818834.7525.6822.2214.92
Adjusted Net Profit 13.72220.72315.83.1-37.8-23.2-11.2-21.9
Net Op. Cash Flow (Rs. Cr.) 10.5-1.910.2-13.5-14.714.1-104.61.80
Debt to Cash Flow from Ops 0.1-0.581.23-3.03-2.712.6-4.7310.0726.695,54,260.65
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Camson Bio Technologies Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -26.5%-49.1%-41.9%-74.2%
Adjusted EPS -198.3%-203.2%NANA
Book Value per Share -11.2-28.7-24.6-32.9
Share Price -28.8% -45.2% -41.8% -58.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 23.6524.1217.8216.048.121.25-20.54-25.6-15.63-39.31
Operating Profit Margin (%) 20.2822.819.5623.5516.9510.94-56.55-127.650.18-329.38
Net Profit Margin (%) 17.0722.2918.4619.2310.831.81-148.9-224.14-58.15-440.02
Debt to Equity 0.010.010.10.280.190.140.450.60.731.11
Working Capital Days 1422262973543853821,7451,8718993,057
Cash Conversion Cycle 1251882372702752991,3566064832,737
Entity Percentage Holding
Promoters 24.46%
Institutions 19.57%
Non-Institutions 55.97%
Pledged *26.4926.4926.4926.4926.4926.4926.4926.4926.4926.49
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Camson Bio's performance infers:

Camson Bio earnings have declined by -203.2%, whereas share price has depreciated -45.2% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Camson Bio share prices over the last 10 years. Here is what we found out:

Camson Bio share price has depreciated -33.2% annually over the past ten years.

Camson, incorporated in 1993 is India's first wholly integrated Agriculture Biotechnology, is based at Bangalore, garden city of India. It became a Public Company in 1995. Camson has been promoted by technocrats with vast relevant experience. Its Vision is to create a healthy and disease free society by providing safe food. This vision forms the guiding beacon of Camson in its pursuit for wholesome goodness in agriculture and aims at being world class manufacture of Biotechnology

Camson, incorporated in 1993 is India's first wholly integrated Agriculture Biotechnology, is based at Bangalore, garden city of India. It became a Public Company in 1995. Camson has been promoted by technocrats with vast relevant experience. Its Vision is to create a healthy and disease free society by providing safe food. This vision forms the guiding beacon of Camson in its pursuit for wholesome goodness in agriculture and aims at being world class manufacture of Biotechnology products

The Company has a strong presence in the Indian market and has unique research and intellectual proprietary which gives the Company an edge over others. Its proprietary technology platform consists of microorganism database, superior proprietary seeds germplasm, screening technology, biocides, biofertilisers and hybrid seeds.

Camson has developed many unique biocides for plant protection and hybrid seeds for improved productivity. Their superior technology in crop transformation and functional genomics has helped in developing new products which are first of its kind in the country.

The infrastructure set up of the Company is at Bangalore North. The set up provides for a total composite production. It is State-of-the-art and spread over 20 acres of land. This affords a high level of space for multi-product production, simultaneously. The Company constantly upgrades its production facilities to keep pace with the increased demand for its products as also for producing a wider range of products pursuant to the success achieved on its research front.

Product range of the company includes:

  • Bio Fungicides
  • Bio Insecticides
  • Bio Stimulants
  • Bio Fertilisers
  • Hybrid Seeds

Achievements/ recognition:

  • Camson Bio Technologies has been recognized, for the second year in succession, as one of the fastest growing technology companies and placed at 17th position, in the Technology 50 India 2008 programme conducted by Deloitte Touche Tohmatsu, Asia Pacific.
  • Camson was declared a Stellar performer for the second year in a row under Technology Fast 500 Asia Pacific Ranking and CEO Survey 2008, obtaining 131st rank out of 500 companies identified by Deloitte.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback